CRISPR 技術市場規模、佔有率、成長分析（按產品、應用、最終用戶和地區）—2025 年至 2032 年產業預測

2023 年 CRISPR 技術市場規模價值為 35 億美元，預計將從 2024 年的 40.8 億美元成長到 2032 年的 138.4 億美元，預測期內（2025-2032 年）的複合年成長率為 16.5%。

CRISPR 技術（成簇的規律間隔的短回文重複序列）徹底改變了基因編輯，使對任何 DNA 序列進行精確修改成為可能。這項特性使得糾正基因缺陷、消除疾病、提高作物產量品質成為可能。利用合成的嚮導RNA和Cas9核酸酶，研究人員可以透過精確的切割進行有針對性的基因組修飾，從而有效地徹底改變基因編輯方法。全球 CRISPR 市場受到微生物應用日益成長以及公共和私人對基因組研究的大量投資的推動。此外，遺傳疾病的流行正在推動對 CRISPR 應用的需求，尤其是在作物改良方面。然而，CRISPR 技術的倫理問題和有限的專業知識帶來的挑戰可能會在短期內影響市場成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

CRISPR 技術市場規模（依產品及服務）及複合年成長率（2025-2032）

• 市場概覽
• 產品
  • CRISPR套件和酶
  • CRISPR文庫
  • 其他產品
  • 設計工具
  • 抗體
  • 其他試劑
• 服務
  • GRNA設計與載體構建
  • 細胞株工程
  • 篩檢服務
  • 其他服務
  • 表觀基因編輯
  • 轉錄活化

CRISPR 技術市場規模：按應用和複合年成長率（2025-2032）

• 市場概覽
• 藥物研發
• 農業
• 其他用途
  • 生質燃料
  • 獸醫

CRISPR 技術市場規模（依最終用戶和複合年成長率）(2025-2032)

• 市場概覽
• 製藥和生物技術公司
• 學術研究所
• 其他
  • CRO
  • CDMOs

CRISPR 技術市場規模：按地區和複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• CRISPR Therapeutics（Switzerland/USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Beam Therapeutics（USA）
• Mammoth Biosciences（USA）
• Caribou Biosciences（USA）
• Synthego（USA）
• ERS Genomics（Ireland）
• Takara Bio（Japan）
• Merck KGaA（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（Integrated DNA Technologies（IDT））（USA）
• Horizon Discovery（PerkinElmer Inc.）（UK/USA）
• GenScript（USA）
• Agilent Technologies（USA）
• New England Biolabs（USA）
• Cellectis（France）
• Sangamo Therapeutics（USA）
• Addgene（USA）
• Biocytogen Co., Ltd.（China）

結論和建議

CRISPR Technology Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 4.08 billion in 2024 to USD 13.84 billion by 2032, growing at a CAGR of 16.5% during the forecast period (2025-2032).

CRISPR technology, or Clustered Regularly Interspaced Short Palindromic Repeats, has revolutionized genetic editing by allowing precise modifications to any DNA sequence. This capability enables the correction of genetic defects, disease elimination, and enhancement of crop yield quality. By utilizing synthetic guide RNA and Cas9 nuclease, researchers can create targeted genome alterations through precise cuts, effectively transforming genetic editing methodologies. The global CRISPR market is significantly driven by increased microbiological applications and substantial public and private investments in genome research. Additionally, the prevalence of genetic diseases heightens the demand for CRISPR applications, particularly in crop improvement. However, ethical issues and limited expertise in CRISPR technology pose challenges that may impact market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR Technology Market

Several factors are driving the growth of the CRISPR technology market, particularly in developed regions like North America and Europe, where increased funding for genetic research is prevalent. Significant investments from government agencies in the United States are enhancing advancements in materials, equipment, and methodologies related to genetic research. This financial support plays a crucial role in fostering medical breakthroughs, particularly for rare genetic diseases. Furthermore, European markets are reaping the benefits of genomic research funding initiatives, such as those provided by the National Human Genome Research Institute, further promoting innovation and progress within the CRISPR industry.

Restraints in the CRISPR Technology Market

The CRISPR Technology market faces significant restraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing innovative genome editing solutions requires substantial investment of time and resources. Although the potential applications of CRISPR gene detection and diagnostic assay kits, as well as therapeutic treatments, are extensive, these expenses ultimately fall upon patients, limiting accessibility. The financial burden can hinder the widespread adoption of CRISPR technologies, posing challenges for both patients seeking treatment and providers aiming to develop effective, affordable genome editing tools. This economic barrier is a critical concern affecting the growth of the market.

Market Trends of the CRISPR Technology Market

The CRISPR technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML), enhancing the efficiency and precision of gene editing processes. This synergy allows for superior target identification and off-target prediction, significantly streamlining research in drug discovery and diagnostics. As AI and ML tools enable rapid analysis of vast datasets, they facilitate the identification of therapeutic targets, leading to more effective treatments and innovations in genetic research. Consequently, the convergence of these technologies is propelling the CRISPR market forward, aligning with a broader shift towards automation and intelligence in biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations